ATS News – David Prezant, MD
ATS News
ATS News
Low-quality evidence shows that people with COPD walk more slowly than healthy controls, which could contribute to an increased risk of falls. Evidence for alterations…
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut…
American Thoracic Society
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut…
Hypoglossal nerve stimulation reduced obstructive sleep apnea severity; however, this outcome was less likely among those with higher BMIs and those who slept in supine…
How are pediatric respiratory health outcomes affected by airway obstruction with a low FEV1 (classic obstruction) vs normal FEV1 (dysanaptic obstruction)?
When added to maintenance therapy for moderate to severe COPD, ensifentrine improves lung function and exacerbation rate vs. placebo, according to a draft evidence report…
Background Individual exposure to environmental pollutants, as one of the most influential drivers of respiratory disorders, has received considerable attention due to its preventability and…
Significant inconsistencies in respiratory care provision for Duchenne muscular dystrophy (DMD) are reported across different specialist neuromuscular centres in the UK. The absence of robust…
Asthma biologics reduce exacerbations and hospitalisations, improve lung function, asthma control and quality of life, and limit the use of systemic corticosteroids, with a favourable…